4/29/2013

CytoVas will work with Becton Dickinson to advance the development of a blood-based test that can be used to identify a person's risk for stroke and cardiovascular disease. The partnership will aid CytoVas in evaluating cardiovascular disease progression and complications tied to experimental and existing cardiovascular drugs.

Full Story:
MedCityNews.com

Related Summaries